Featured
-
Vanderbilt establishes open access publishing agreement for ‘Nature’ and other leading science journals
“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read MoreMar. 10, 2025
-
Vanderbilt biomedical research paves the way for ‘hypoallergen’ treatments against peanut allergies
Peanuts cause the highest number of food allergy–related deaths in the U.S. Basic scientists at Vanderbilt uncover how the allergy works and suggest new potential treatments. Read MoreFeb. 24, 2025
-
Carrie Jones wins Wellcome Trust Discovery Award to combat opioid misuse and addiction
Great Britain’s Wellcome Trust has recognized Vanderbilt’s Carrie K. Jones and the University of Glasgow’s Andrew Tobin with their prestigious Discovery Award. The pair will study how blocking the M5 muscarinic receptor in the brain counteracts opioids’ addictive properties, which could lead to new treatments for preventing or addressing opioid addiction. Read MoreFeb. 10, 2025
-
Hwang joins VUMC and the Center for Computational Systems Biology
Tae Hyun Hwang, a national leader in the use of AI to improve cancer diagnosis and treatment, will lead a new “Molecular AI” initiative within Vanderbilt University Medical Center. He was jointly recruited by the Department of Surgery and the newly established Center for Computational Systems Biology led by Ken Lau. Read MoreJan. 21, 2025
-
Warren Center for Neuroscience Drug Discovery researchers create new compound to potentially treat negative and positive symptoms of schizophrenia
Researchers from the Warren Center for Neuroscience Drug Discovery, in collaboration with Boehringer Ingelheim, developed a compound that can treat both negative and positive symptoms of schizophrenia in rodents. The compound holds promise as an investigational tool and an inspiration for novel schizophrenia therapies. Read MoreJan. 16, 2025
-
Center for Computational and Systems Biology applies advanced technology to biological research
The Center for Computational and Systems Biology, launching at Vanderbilt University in early 2025, will focus on analyzing vast amounts of data to look for new ways to tackle human diseases and conditions. Read MoreJan. 16, 2025
-
Doug Mitchell, a generational leader in chemical biology, named professor of biochemistry and chemistry and director of the Vanderbilt Institute of Chemical Biology
A leading chemical biologist working on ribosomally synthesized and post-translationally modified peptides, Doug Mitchell has joined the School of Medicine Basic Sciences as the William Kelly Warren Sr. Professor of Biochemistry and director of the Vanderbilt Institute for Chemical Biology. He also has been named professor of chemistry. Read MoreJan. 1, 2025
-
School of Medicine Basic Sciences: 2024 in review
As 2024 comes to a close, we take a look back at the accomplishments and contributions to science and society made by School of Medicine Basic Sciences community members throughout the past year. The efforts of our faculty, trainees, staff, and collaborators have resulted pioneering discoveries that tangibly benefit society. Read MoreDec. 20, 2024
-
Vanderbilt CTTC honors three SOM Basic Sciences faculty as newly inducted Master Innovators
Vanderbilt University has announced this year’s Master Innovators including Carrie Jones, Colleen Niswender, and Alex Waterson. The recognition, presented by the Center for Technology Transfer and Commercialization, honors faculty whose groundbreaking research has been translated into transformative innovations, advancing their fields and making a significant impact on society. Read MoreDec. 5, 2024
-
Vanderbilt awarded up to $46M through ARPA-H to develop tools against alphaviruses
Jens Meiler, Distinguished Research Professor of Chemistry and Kevin Schey, Stevenson Chair and professor of biochemistry, are two Vanderbilt collaborators on the project that brings together specialists in virology, structural biology and clinical research to tackle the complex challenge of vaccine development. Read MoreDec. 2, 2024